These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 919379)

  • 21. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia.
    Baethge C; Baldessarini RJ; Freudenthal K; Streeruwitz A; Bauer M; Bschor T
    Bipolar Disord; 2005 Apr; 7(2):136-45. PubMed ID: 15762854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechloamine excretion in manic-depressive and schizophrenic psychosis and its relationship to symptomatology.
    Sloane RB; Hughes W; Haust HL
    Can Psychiatr Assoc J; 1966 Feb; 11(1):6-19. PubMed ID: 5902417
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-Ethylmaleimide sensitive factor in the cortex of subjects with schizophrenia and bipolar I disorder.
    Gray L; Scarr E; Dean B
    Neurosci Lett; 2006 Jan; 391(3):112-5. PubMed ID: 16165270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression.
    De La Garza R; Mahoney JJ
    Brain Res; 2004 Sep; 1021(2):209-18. PubMed ID: 15342269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Ishikawa M; Mizukami K; Iwakiri M; Asada T
    Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-Traumatic Stress Disorder in subjects with schizophrenia and bipolar disorder.
    Kennedy BL; Dhaliwal N; Pedley L; Sahner C; Greenberg R; Manshadi MS
    J Ky Med Assoc; 2002 Sep; 100(9):395-9. PubMed ID: 12357916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression.
    Diaz FJ; James D; Botts S; Maw L; Susce MT; de Leon J
    Bipolar Disord; 2009 Mar; 11(2):154-65. PubMed ID: 19267698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA fragmentation decreased in schizophrenia but not bipolar disorder.
    Benes FM; Walsh J; Bhattacharyya S; Sheth A; Berretta S
    Arch Gen Psychiatry; 2003 Apr; 60(4):359-64. PubMed ID: 12695312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is the schizophrenia diagnosis still appropriate?].
    Häfner H
    Psychiatr Prax; 2007 May; 34(4):175-80. PubMed ID: 17520528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women.
    Hughes JW; Watkins L; Blumenthal JA; Kuhn C; Sherwood A
    J Psychosom Res; 2004 Oct; 57(4):353-8. PubMed ID: 15518669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder.
    Boer S; Berk M; Dean B
    Neurosci Lett; 2009 Nov; 466(1):27-9. PubMed ID: 19765633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolism of norepinephrine in depressions. Differences and effects of therapies.
    Rosenblatt S; Chanley JD
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:50-60. PubMed ID: 5937839
    [No Abstract]   [Full Text] [Related]  

  • 36. [Metabolism of noradrenaline and endogenous depression (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Aug; 48(8):415-37. PubMed ID: 6902692
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neuroendocrinology in depression and schizophrenia (author's transl)].
    Langer G
    Arzneimittelforschung; 1978; 28(8):1280-1. PubMed ID: 582389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological factors relating to activation and inhibition of the adrenocortical stress response in man: a review.
    Sachar EJ
    Prog Brain Res; 1970; 32():316-24. PubMed ID: 4923439
    [No Abstract]   [Full Text] [Related]  

  • 39. Brain noradrenaline and schizophrenia.
    Hornykiewicz O
    Prog Brain Res; 1986; 65():29-39. PubMed ID: 3538161
    [No Abstract]   [Full Text] [Related]  

  • 40. [The significance of endorphins and gamma-aminobutyric acid in clinical psychopharmacology (author's transl)].
    Vinar O
    Cesk Psychiatr; 1978 Apr; 74(2):98-107. PubMed ID: 357024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.